“NemaLife, Inc.”

One-liner: “NemaLife develops AI-enabled technologies for accelerating ingredient discovery and development, focusing on sustainable practices for enterprise clients.”

Company slogan: “A techbio platform company developing AI & microfluidics-based in vivo, in vitro & protein characterization solutions.”

Positioning: “NemaLife positions itself as a transformative player in the TechBio sector, focusing on accelerating ingredient discovery and development through innovative technologies.”

Description: “NemaLife’s mission is to accelerate and de-risk R&D for companies in the food, nutraceutical, microbiome and pharma industries. In these industries, performing human-relevant high throughput biology and doing so with efficiency and speed has been a mutually exclusive affair. NemaLife has solved this major challenge by developing an AI-assisted microfluidics-based in vivo platform based on the microscopic worm C. elegans that has strong relevance for human biology. This 3R-compliant cruelty-free technology capable of testing a variety of compounds and their combinations is an alternative to expensive and time-consuming mouse models.

We work with companies as their R&D partner, accelerating the value-chain from early-phase discovery to assessment of product potency and health claims. Our interdisciplinary team of engineers and biologists work with you to achieve your R&D objectives as well as co-create assets by developing custom biological readouts and new tech platforms. We have significant pre-clinical expertise in human wellness areas related to gut health, brain health, muscle health, metabolic health, cognitive health and healthy aging. We would be happy to share more details in a 15 min call.”

Employees: 31

Website: Visit website

Headquarters: “Lubbock, Texas”

Ownership: Privately Held

Founded: 2018

Company type: AI company

Use cases: “ingredient discovery, preclinical research, sustainable product development”

Pricing: custom pricing based on partnerships

Client sector: enterprise

Business model: partnership-based

Products: “organism-on-chip technology, AI-enabled microfluidic platforms”

Is API available: no

Website title: Ms. AI | Ms. AI Nemes Ventures | Germany

Website description: none

Linkedin: https://www.linkedin.com/company/nemalifeinc

Youtube:

Instagram:

Facebook:

Twitter:

Crunchbase: https://www.crunchbase.com/organization/nemalife

Email: